On Aug. 12, 2014 bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today reported financial results and operational highlights for the quarter ended June 30, 2014. bluebird bio, Inc. (NASDAQ:BLUE) belongs to Healthcare sector. Its weekly performance is -1.27%. On last trading day company shares ended up $33.55. bluebird bio, Inc. (NASDAQ:BLUE) … Continue reading Today’s Watch List: bluebird bio (NASDAQ:BLUE), ReneSola (NYSE:SOL), Primo Water (NASDAQ:PRMW), Weight Watchers International, Inc. (NYSE:WTW), Jumei International (NYSE:JMEI)